Rugowski DE - Search Results

1

Prolactin cooperates with loss of p53 to promote claudin-low mammary carcinomas.

O'Leary KA, Rugowski DE, Sullivan R, Schuler LA. O'Leary KA, et al. Among authors: rugowski de. Oncogene. 2014 Jun 5;33(23):3075-82. doi: 10.1038/onc.2013.278. Epub 2013 Jul 22. Oncogene. 2014. PMID: 23873024 Free PMC article.

2

Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context.

Gutzman JH, Rugowski DE, Nikolai SE, Schuler LA. Gutzman JH, et al. Among authors: rugowski de. Oncogene. 2007 Sep 20;26(43):6341-8. doi: 10.1038/sj.onc.1210454. Epub 2007 Apr 16. Oncogene. 2007. PMID: 17438530 Free PMC article.

3

Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.

Arendt LM, Rugowski DE, Grafwallner-Huseth TA, Garcia-Barchino MJ, Rui H, Schuler LA. Arendt LM, et al. Among authors: rugowski de. Breast Cancer Res. 2011 Jan 28;13(1):R11. doi: 10.1186/bcr2819. Breast Cancer Res. 2011. PMID: 21276249 Free PMC article.

4

Prolactin promotes mammary pathogenesis independently from cyclin D1.

Asher JM, O'Leary KA, Rugowski DE, Arendt LM, Schuler LA. Asher JM, et al. Among authors: rugowski de. Am J Pathol. 2012 Jul;181(1):294-302. doi: 10.1016/j.ajpath.2012.03.041. Epub 2012 May 29. Am J Pathol. 2012. PMID: 22658484 Free PMC article.

5

Prolactin activates ERα in the absence of ligand in female mammary development and carcinogenesis in vivo.

O'Leary KA, Jallow F, Rugowski DE, Sullivan R, Sinkevicius KW, Greene GL, Schuler LA. O'Leary KA, et al. Among authors: rugowski de. Endocrinology. 2013 Dec;154(12):4483-92. doi: 10.1210/en.2013-1533. Epub 2013 Sep 24. Endocrinology. 2013. PMID: 24064365 Free PMC article.

6

Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.

Barcus CE, O'Leary KA, Brockman JL, Rugowski DE, Liu Y, Garcia N, Yu M, Keely PJ, Eliceiri KW, Schuler LA. Barcus CE, et al. Among authors: rugowski de. Breast Cancer Res. 2017 Jan 19;19(1):9. doi: 10.1186/s13058-017-0801-1. Breast Cancer Res. 2017. PMID: 28103936 Free PMC article.

7

A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation.

Campbell KM, O'Leary KA, Rugowski DE, Mulligan WA, Barnell EK, Skidmore ZL, Krysiak K, Griffith M, Schuler LA, Griffith OL. Campbell KM, et al. Among authors: rugowski de. Cell Rep. 2019 Aug 6;28(6):1526-1537.e4. doi: 10.1016/j.celrep.2019.06.098. Cell Rep. 2019. PMID: 31390566 Free PMC article.

8

Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER+ breast cancer.

Jallow F, O'Leary KA, Rugowski DE, Guerrero JF, Ponik SM, Schuler LA. Jallow F, et al. Among authors: rugowski de. Oncogene. 2019 Oct;38(43):6913-6925. doi: 10.1038/s41388-019-0941-0. Epub 2019 Aug 12. Oncogene. 2019. PMID: 31406251 Free PMC article.

9

Prolactin synergizes with canonical Wnt signals to drive development of ER+ mammary tumors via activation of the Notch pathway.

O'Leary KA, Rugowski DE, Shea MP, Sullivan R, Moser AR, Schuler LA. O'Leary KA, et al. Among authors: rugowski de. Cancer Lett. 2021 Apr 10;503:231-239. doi: 10.1016/j.canlet.2021.01.012. Epub 2021 Jan 17. Cancer Lett. 2021. PMID: 33472091 Free PMC article.

10

Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells.

Gutzman JH, Rugowski DE, Schroeder MD, Watters JJ, Schuler LA. Gutzman JH, et al. Among authors: rugowski de. Mol Endocrinol. 2004 Dec;18(12):3064-75. doi: 10.1210/me.2004-0187. Epub 2004 Aug 19. Mol Endocrinol. 2004. PMID: 15319452 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters